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A prominent region of the vertebrate hindbrain is subdivided along the anterior–posterior axis into a series of seven segments, or
rhombomeres. The identity of each rhombomere is specified by the expression of conserved transcription factors, including Krox-20, vHnf1,
Val (Kreisler, Mafb) and several Hox proteins. Previous work has shown that retinoic acid (RA) signaling plays a critical role in regulating
the expression of these factors and that more posterior rhombomeres require higher levels of RA than more anterior rhombomeres. Models to
account for RA concentration dependency have proposed either a static RA gradient or increasing time periods of RA exposure. Here, we
provide evidence against both of these models. We show that early zebrafish rhombomere-specification genes, including vhnf1 in r5–r6 and
hoxd4a in r7, initiate expression sequentially in the hindbrain, each adjacent to the source of RA synthesis in paraxial mesoderm. By
knocking down RA signaling, we show that progressively more posterior rhombomeres require increasingly higher levels of RA signaling,
and vhnf1 and hoxd4a expression are particularly RA-dependent. RA synthesis is required just at the time of initiation, but not for
maintenance, of vhnf1 and hoxd4a expression. Furthermore, a premature RA increase causes premature activation of vhnf1 and hoxd4a
expression. Our results support a new model of dynamic RA action in the hindbrain, in which a temporally increasing source of RA is
required to sequentially initiate progressively more posterior rhombomere identities.
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A major part of the vertebrate hindbrain is subdivided
along the anterior–posterior axis into seven segments, or
rhombomeres. A conserved set of transcription factors
specifies the development and identity of each rhombomere
(reviewed by Moens and Prince, 2002 and by Schneider-
Maunoury et al., 1998). These factors include Krox-20,
vHnf1, Val (Kreisler, Mafb) and several Hox proteins. For
example, Val and Kreisler are required for the proper
development of r5–r6 in zebrafish and mice, respectively,
and Hoxb1 is important in r4 development. Because the0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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development of rhombomere-specific neurons and other
cell types, understanding how these factors become properly
initiated is an important problem.
Retinoic acid (RA) signaling plays a critical role in
specifying rhombomere identity by acting upstream of these
transcription factors, particularly in the posterior hindbrain
(reviewed by Gavalas and Krumlauf, 2000 and by Maden,
2002). Studies in amniote embryos have shown that RA is
required in both a concentration- and time-dependent
manner for development of r5–r7, where more posterior
rhombomeres require higher levels and longer time periods
of RA signaling (Dupe´ et al., 1999; Gale et al., 1999;
Niederreither et al., 2000; White et al., 2000; Dupe´ and
Lumsden, 2001; Wendling et al., 2001). With the strongest
and earliest loss of RA signaling, r5–r7 are lost, expression
of Krox-20 in r5 and kreisler, orMafb, in r5–r6 are lost, and
r3–r4 appear expanded. This phenotype is exemplified by285 (2005) 593 – 605
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enzyme that synthesizes RA from retinal (Niederreither et
al., 2000). Mild or late reduction of RA signaling causes
loss of r7, accompanied by slight expansion of r5–r6
(reviewed by Begemann and Meyer, 2001 and Gavalas,
2002). The requirements for RA signaling in the zebrafish
hindbrain are beginning to be elucidated (Begemann et al.,
2001; Grandel et al., 2002; Linville et al., 2004; Begemann
et al., 2004). The zebrafish raldh2 mutant shows posterior
hindbrain and spinal cord defects, including expansion of
val expression and r5–r6, consistent with a mild defect in
RA signaling in the hindbrain (Begemann et al., 2001;
Grandel et al., 2002). It is not yet clear whether the role of
RA in zebrafish r5–r7 development is both concentration-
and time-dependent, as in other vertebrates.
An RA gradient across the hindbrain, with high posterior
levels and lower anterior levels, would explain the concen-
tration dependency (reviewed by Gavalas and Krumlauf,
2000; Maden, 2002). Although direct visualization of an RA
gradient has been elusive, two findings support the presence
of a hindbrain RA gradient. First, the RA source appears to
be local. A high source of RA is likely generated by the
expression of raldh2 in somite tissue just posterior to the
hindbrain (Niederreither et al., 1997; Berggren et al., 1999;
Niederreither et al., 1999; Swindell et al., 1999; Chen et al.,
2001; Begemann et al., 2001; Grandel et al., 2002).
Hindbrain defects in zebrafish raldh2 mutants can be
rescued by wild-type cells placed in the somites (Begemann
et al., 2001; Linville et al., 2004). Somite grafting experi-
ments in chick and mouse embryos have further supported a
role for mesodermal tissue just posterior to the hindbrain as
a source for an RA signal (Itasaki et al., 1996; Gould et al.,
1998; Grapin-Botton et al., 1998). Second, there is a
putative sink for the gradient. Cyp26, an enzyme that
metabolizes RA, is expressed in the anterior hindbrain and is
proposed to function as a sink for RA (Swindell et al., 1999;
Abu-Abed et al., 2001; Sakai et al., 2001; Kudoh et al.,
2002; Dobbs-McAuliffe et al., 2004).
If an RA gradient exists, it does not appear to be static.
For example, grafting experiments in chick embryos have
shown that the ability of somite tissue, the putative source of
an RA gradient, to induce ectopic Hox gene expression in
the anterior hindbrain moves posteriorly during develop-
ment (Itasaki et al., 1996). To account for the fact that more
posterior rhombomeres require both higher levels of, and
earlier exposure to, RA, duration of exposure to RA has
been proposed as an alternative to a fixed anterior–posterior
gradient of RA (Gavalas, 2002; Maden, 2002). In this
model, cells of posterior rhombomeres, which develop later
than more anterior rhombomeres, would be exposed to a
constant source of RA for longer time periods before their
specification, thus achieving a higher effective RA concen-
tration. A recent study examining dynamic expression
patterns of Cyp26 enzymes has provided further support
that posterior rhombomeres experience longer exposure to
RA than more anterior rhombomeres (Sirbu et al., 2005).However, it is still not clear how the temporal requirements
for RA are integrated with its concentration dependence.
Here, we address the nature of RA action in the zebrafish
posterior hindbrain. We show that the expression of early
posterior rhombomere-specification genes, including vhnf1
and hoxd4a, initiates sequentially in the hindbrain, near the
source of RA synthesis in paraxial mesoderm. Using genetic
and pharmacological approaches to knock down RA signal-
ing, we show that progressively more posterior rhombomere
markers require increasingly higher levels of RA signaling,
and vhnf1 and hoxd4a expression are particularly RA-
dependent. RA synthesis is required for initiation, but not
for maintenance, of vhnf1 and hoxd4a expression, and RA
signaling is not required until just at the time of initiation of
their expression.We further show that a premature increase of
RA can cause premature activation of vhnf1 and hoxd4a
expression. We also show that RA regulates val expression in
r5– r6 through vHnf1. Our results from spatially and
temporally manipulating RA levels and RA synthesis argue
against a role for either a static gradient of RA signaling
across the hindbrain RA or a requirement for temporal
exposure to RA. Instead, our results support a role for a tem-
porally increasing source of RA during hindbrain develop-
ment. These results support a model of dynamic RA action in
the hindbrain, in which a temporally increasing source of RA
is required to sequentially initiate progressively more
posterior rhombomere markers.Materials and methods
Zebrafish stocks
Zebrafish (Danio rerio) were raised and staged as
previously described (Westerfield, 1995; Kimmel et al.,
1995). Time (hpf) refers to hours post-fertilization at
28.5-C. In some cases, embryos were raised for periods at
room temperature, about 25-C. The wild-type stock used
was AB. The necklessi26 line, a strong hypomorph for
raldh2 (aldh1a2—Zebrafish Information Network) has
been described (Begemann et al., 2001). Homozygous
raldh2 mutant embryos were identified by PCR genotyping
(Hernandez et al., 2004). Homozygous mutant embryos for
vhnf1hi2169, a likely null or strong hypomorphic allele, were
identified by loss of val in r5/r6 (Sun and Hopkins, 2001).
RNA in situ hybridization
RNA in situ hybridizations were performed as previously
described (Maves et al., 2002). The following cDNA probes
were used: raldh2 (Begemann et al., 2001); hoxb1b
(Alexandre et al., 1996); pax2a (Krauss et al., 1991); vhnf1
(Sun and Hopkins, 2001); hoxb1a (Prince et al., 1998a);
hoxd4a (Prince et al., 1998b); krox-20 (Oxtoby and Jowett,
1993); valentino (Moens et al., 1998); ephrinb2a (Cooke et
al., 2001); no tail (Schulte-Merker et al., 1992). Embryos
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scope and Nikon Coolpix 4500 digital camera or a Zeiss
Axiophot 2 microscope. Images were assembled using
Adobe Photoshop 7.
Pharmacological treatments
The following stock solutions were made and stored at
80-C: 100 mM 4-(Diethylamino)-benzaldehyde (DEAB;
Aldrich) in DMSO; 10 mM or 1 mM all-trans retinoic acid
(RA; Sigma) in DMSO. 10 mM BMS493 (Bristol Myers
Squib; gift from Vicky Prince) in 50% ethanol was stored at
20-C. For embryo treatments, dilutions of these chemicals
were made in Embryo Medium (EM) supplemented with
penicillin (5000 U/L)/streptomycin (100 mg/L; Sigma).
Embryos, still in chorions, were transferred into Petri dishes
containing the treatment solution. For control treatments,
sibling embryos were incubated in corresponding dilutions
of DMSO or, for BMS493 treatments, 50% ethanol. All
incubations were done in the dark.
To demonstrate the specificity of DEAB, we incubated
embryos in DEAB with 1 nM RA and found that we could
completely rescue the effects of DEAB (see Results).
Concentrations of DEAB higher than 25 AM, or of
BMS493 higher than 10 AM, showed non-specific effects
and, in the case of DEAB, could not be rescued by RA. We
tested the efficacy of DEAB inhibition of RA signaling by
using a transgenic RA reporter line, RGYn2 (Perz-Edwards
et al., 2001). With treatments initiating at 4 hpf (sphere
stage), 5 AM DEAB concentrations cause loss of reporter
expression, and lower DEAB concentrations cause reduc-
tion of expression (data not shown; see also Perz-Edwards et
al., 2001). Furthermore, initiating 5 AM DEAB treatments at
10.3 hpf (1 somite stage (s)) causes loss of RA reporter
expression (data not shown), showing that DEAB can
function late. These controls all support the specificity and
utility of these inhibitors in blocking RA signaling.
To quantify changes and variability in hindbrain RNA
expression patterns after pharmacological manipulations, we
sorted stained embryos into groups based on relative levels of
expression and assigned each embryo within a group a score
of 0, 1, 2, 3 or 4, where 0 is no hindbrain expression and 4 is
wild-type level of hindbrain expression. In cases where we
scored rhombomere length along the anterior–posterior axis,
we sorted embryos into groups and assigned each embryo a
score of 0, 1, 2 or 3, where 0 is no rhombomere present and 3
is wild type or longer rhombomere length. We found these
approaches to give very reproducible results. Calculations
and graphing were performed in Microsoft Excel.
Bead implantations
To make retinoic acid beads, AG1-X8 beads (200–400
mesh, Formate form; Bio-Rad) were quickly rinsed twice in
EM with pen/strep and then were incubated in all-trans RA
(Sigma), diluted to the appropriate concentration in DMSO,for 20 min at room temperature in the dark. Control beads
were incubated in DMSO. Beads were then quickly rinsed
twice in EM with pen/strep and stored on ice in the dark. All
beads were prepared the same day they were used for
implantation. Bead implants were carried out at 6 hpf (shield
stage) as previously described (Maves et al., 2002). RA
bead experiments were performed with little overhead
lighting, and embryos with implanted RA beads were stored
in the dark.Results
The expression of rhombomere-specification transcription
factors initiates sequentially near the source of RA synthesis
To address the roles of RA signaling in promoting early
hindbrain development in zebrafish, we compared the
initiation of expression of rhombomere-specification genes
with respect to the source of RA synthesis. As a marker for
the source of RA, we used raldh2, which is expressed in
early mesendodermal cells and persists in paraxial meso-
derm (Begemann et al., 2001; Grandel et al., 2002; Figs.
1A–D). The rhombomere-specification genes that we
analyzed are hoxb1b (formerly called hoxa1; Alexandre et
al., 1996) and hoxb1a, required for proper development of
r4 (McClintock et al., 2002), vhnf1, required for the
development of r5–r6 (Sun and Hopkins, 2001; Wiellette
and Sive, 2003), and hoxd4a, which we find to be the
earliest zebrafish hox4 gene expressed in presumptive r7
(see below and data not shown). We find that the initial
expression of each of these genes occurs sequentially in the
presumptive hindbrain adjacent to raldh2-expressing cells
(Fig. 1). hoxb1b expression initiates at about 6.5 hpf
(McClintock et al., 2001; Fig. 1E). Over the next 3 h of
development, hoxb1b continues to be expressed, with
anterior-most expression at the r3/r4 boundary (McClintock
et al., 2001; Figs. 1F–H). vhnf1 expression initiates at about
8 hpf in cells posterior to the most anterior hoxb1b-
expressing cells (compare Figs. 1I with F; see also Wiellette
and Sive, 2003). hoxb1a initiates at about 9 hpf, with
anterior-most expression at the r3/r4 boundary (Prince et al.,
1998a; Figs. 1L–M). hoxd4a initiates at about 10.3 hpf
(Fig. 1N), with anterior-most expression at the r6/r7
boundary (L. M., data not shown; Prince et al., 1998b).
Thus, these genes with important functions in the develop-
ment of r4–r7 turn on sequentially, and, with the exception
of hoxb1a, increasingly more posteriorly in the presumptive
hindbrain, near the source of RA synthesis in early
mesendoderm and paraxial mesoderm.
Increasingly more posterior rhombomeres require
increasingly higher levels of RA signaling
We next addressed the requirements for RA signaling in
promoting expression of these rhombomere-specification
Fig. 1. Rhombomere-specification factors initiate expression sequentially near the source of RA synthesis. Wild-type embryos are stained in blue for raldh2
(A–D), hoxb1b (E–H), vhnf1 (I –K), hoxb1a (L–M) and hoxd4a (N). Other markers in red are pax2a to label the early midbrain–hindbrain boundary (MHB,
Krauss et al., 1991; C–D, G–H, J–K, L–M, N) and raldh2 (E–N). Dorsal views show anterior to the top. Stages are shown at the top of each column: 6.5 hpf
(60% epiboly) (A, E), 8 hpf (80% epiboly) (B, F, I), 9 hpf (90% epiboly) (C, G, J, L), 10.3 hpf (1 somite (s)) (D, H, K, M, N). Double labels of raldh2 (in red)
and hoxb1b (E), vhnf1 (I), hoxb1a (L) and hoxd4a (N) show that these four factors initiate near the source of RA synthesis. Scale bar: 50 Am.
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raldh2 mutant embryos show posterior expansion of r3–r6,
consistent with a reduced level of RA signaling (Begemann
et al., 2001; Grandel et al., 2002). hoxb1b is slightly reduced
in raldh2 mutants (Grandel et al., 2002; Fig. 2B). vhnf1
expression is slightly reduced in some raldh2 mutants (Fig.
2F) but appears normal in others (not shown). We confirmed
that r3–r6 are slightly posteriorly expanded in raldh2
mutants, based on expression of hoxb1a in r4 (Fig. 2J),
krox-20 in r3 and r5 (Figs. 2J, N, R) and val in r5 and r6
(Fig. 2N; see also Table 1; Begemann et al., 2001; Grandel
et al., 2002). hoxd4a is only subtly reduced in r7 and the
anterior spinal cord in raldh2 mutants (Fig. 2R; Table 1), in
contrast to hoxb4a, which shows more severe reduction of
expression in raldh2 mutants (Begemann et al., 2001;
Grandel et al., 2002). To further assess the effect on r7, wefind that efnb2a expression in r7 appears reduced in raldh2
mutants (Fig. 2V; although see Begemann et al., 2001).
These results are consistent with expansion of r3–r6 and
reduction of r7 in zebrafish raldh2 mutants, similar to what
has been observed upon mild reduction of RA signaling in
other vertebrates (reviewed by Begemann and Meyer, 2001;
Gavalas, 2002).
To further knock down RA signaling in zebrafish, we
turned to the pharmacological inhibitors 4-(Diethylamino)-
benzaldehyde (DEAB), a potent retinaldehyde dehydrogen-
ase inhibitor, and BMS493, a pan-RA-receptor inhibitor
(Russo et al., 1988; Wendling et al., 2000). We applied
either of these inhibitors at 4 hpf, just before initiation of
raldh2 expression (Begemann et al., 2001; Grandel et al.,
2002), and maintained embryos in the treatment bath.
Treating embryos with low concentrations of either inhibitor
Fig. 2. Posterior rhombomere markers require progressively higher levels of RA signaling. Embryos are stained in blue for hoxb1b at 10 hpf (bud stage) (A–D),
vhnf1 at 10.3–10.6 hpf (1–2 s) (E–H), at 18–19 hpf (18–20 s), hoxb1a (I –L), val (M–P) and hoxd4a (Q–T) and efnb2a at 11.6 hpf (5 s) (U–X). Other markers
in red are pax2a, to label theMHB (A–H) and inner ear (I–T), and krox-20 (E–X), which labels r3 and r5 (Oxtoby and Jowett, 1993). Dorsal views show anterior
to the left. Pharmacological treatment or genotype is shown at the top of each column. Control embryos treatedwithDMSO showwild-type expression patterns (A,
E, I, M, Q, U). raldh2 mutant embryos show subtle reduction in expression of hoxb1b (B, 7/7 embryos), vhnf1 (F, 9/11 embryos), hoxd4a (R, 9/9 embryos) and
efnb2a (V, 14/14 embryos show reduced expression in r7) and slight expansion of hoxb1a in r4 (J, 9/9 embryos), krox-20 in r3 and r5 (J, N, R, 17/17 embryos) and
val in r5/r6 (N, 8/8 embryos). 1 AMDEAB-treated embryos showmore severe reduction in expression of hoxb1b (C, 18/18 embryos), vhnf1 (G, 18/18 embryos),
krox-20 in r5 (K, O, S, 38/47 embryos), val in r5/r6 (O, 18/23) and hoxd4a (S, 24/24 embryos), greater expansion of domains of krox-20 in r3 (K, O, S, 47/47
embryos) and hoxb1a in r4 (K, 21/21 embryos) and loss of efnb2a in r7 (W, 17/17 embryos). 1 AM DEAB-treated embryos can also show expansion of r5 and
reduced r6 (not shown, 9/47 embryos). 5 AM DEAB-treated embryos show even more severe reduction of hoxb1b expression (D, 15/15 embryos), loss of
expression of vhnf1 (H, 15/15 embryos), krox-20 in r5 (L, P, T, 31/41 embryos), val in r5– r6 (P, 20/28 embryos) and efnb2a in r7 (X, 17/17 embryos), and even
greater expansion of domains of krox-20 in r3 (L, P, T, 41/41 embryos) and hoxb1a in r4 (L, 12/12 embryos). The val-expressing cells in r4 are the Mauthner
neurons (Moens et al., 1998). The arrows in U–X point to efnb2a expression in developing somites (Durbin et al., 1998), posterior to the r7 efnb2a domain in
control (U) and raldh2 mutant (V) embryos. r3, rhombomere 3 krox-20 expression. Scale bars: 50 Am.
L. Maves, C.B. Kimmel / Developmental Biology 285 (2005) 593–605 597generates hindbrain phenotypes that resemble zebrafish
raldh2 mutants (Table 1; Grandel et al., 2002). Treating
embryos with a series of higher concentrations of either
inhibitor generates a series of more severe hindbrain
phenotypes. With 1 AM DEAB, hoxb1b and vhnf1
expression are severely reduced (Figs. 2C, G), and with 5
AM DEAB, vhnf1 expression is lost (Fig. 2H). With
intermediate inhibitor doses, we observe loss of r7, pro-
gressive reduction of r5 and r6 and posterior expansion of r3
and r4 (Table 1; Figs. 2K, O, S, W). For efnb2a, we interpret
the strong hindbrain expression domain as expanded r4,
with loss of the r7 domain (Fig. 2W). Finally, with the
highest dose of either inhibitor that acts specifically (see
below and Materials and methods), we observe loss of r5–
r7 and greater posterior expansion of r3 and r4 (Table 1;
Figs. 2L, P, T, X). This series of phenotypes very closely
resembles those reported for intermediate and severeinhibition of RA signaling in other vertebrates (reviewed
in Begemann and Meyer, 2001; Gavalas, 2002). These
results show that, at the level of r5–r7, increasingly more
posterior rhombomeres require increasingly higher levels of
RA signaling.
Increasingly more posterior rhombomere markers require
RA signaling at progressively later stages
In addition to concentration, timing of RA signaling has
been proposed to be an important component of RA action in
the posterior hindbrain (reviewed in Begemann and Meyer,
2001; Gavalas, 2002). Because vhnf1 and hoxd4a have very
strong requirements for RA signaling, we asked whether RA
signaling is required for the initiation or maintenance of
expression of vhnf1 and hoxd4a. Following DEAB treatment
beginning at 4 hpf, we find no initiation of hindbrain
Table 1
Rhombomere defects observed after RA inhibitor treatments at varying concentrations, compared to raldh2 mutant phenotype
Genotype Number of
embryos
analyzeda
Normal
hindbrain
pattern
r3– r6 slightly
enlarged,
r7 reduced
r3– r5 enlarged,
r6 reduced,
r7 absent
r3– r4 enlarged,
r5– r6 reduced,
r7 absent
r3– r4 enlarged,
r5– r7 absent
Raldh2+/ or +/+ 11 100%
Raldh2/ 17 100%
Inhibitor
applied
Concentration
DMSO 0.005% 34 100%
DEAB 0.25 AM 40 40% 60%
0.5 AM 40 17% 30% 38% 15%
1 AM 47 19% 72% 9%
5 AM 41 24% 76%
EtOH 0.05% 21 100%
BMS493 1 AM 22 32% 68%
2.5 AM 25 4% 40% 48% 8%
5 AM 23 4% 13% 74% 9%
10 AM 24 17% 79% 4%
a For all cases, rhombomeres were scored at 18 hpf (18 s) using expression of val+krox-20 or hoxd4a+krox-20. Rhombomere size was judged as marker gene
expression domain length along the anterior–posterior axis. Similar percentages were observed for either of the two probe combinations for a given treatment,
and numbers were combined. r7 was scored by hoxd4a expression; the r7 marker efnb2a gave similar results (see Fig. 2).
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RA signaling is required for the initial expression of vhnf1
and hoxd4a. To test whether RA signaling is required before
or after the time of initiation of vhnf1 and hoxd4a expression,
we applied DEAB or BMS493 at a series of developmental
stages. We find that inhibiting RA synthesis just before the
initiation of vhnf1 or hoxd4a expression is sufficient to block
or severely reduce their expression (Fig. 3E). However, if
embryos are treated with DEAB after vhnf1 or hoxd4a
expression is initiated, their expression appears normal (Fig.
3E). We also assessed when RA signaling is required for the
specification of individual posterior rhombomeres, judging
specification by the appearance of markers krox-20 for r5, val
(non-overlapping r5 krox-20) for r6 and efnb2a for r7. We
find that specification of r5–r6 and r7 follows a similar
temporal requirement for RA synthesis as vhnf1 and hoxd4a,
respectively (Fig. 3F). Inhibiting RA signaling with BMS493
at this series of stages gave similar results (data not shown).
Therefore, RA synthesis and signaling are required for
initiation, but not maintenance, of vhnf1 and hoxd4a and
for the progressive specification of r5–r7. Taken together, our
results are consistent with those seen for time and concen-
tration dependence of RA in chick andmouse embryos (Dupe´
and Lumsden, 2001; Wendling et al., 2001).
Because increasingly more posterior rhombomere
markers initiate later in development and because specifi-
cation of increasingly more posterior rhombomeres requires
increasingly higher levels of RA signaling, we wondered
whether increasingly more posterior rhombomere markers
require an increasingly longer time period of RA signaling.
To address this, we inhibited RA synthesis at 4 hpf and then
added exogenous RA to the embryo medium at progres-
sively later stages. The exogenous RA concentration used in
these rescue experiments, 1 nM, causes only very subtle orno hindbrain defects in control embryos (Figs. 4A–B, E–
F). While 5 AM DEAB treatments beginning at 4 hpf cause
loss of vhnf1 and hoxd4a expression (Figs. 4C, G), adding
RA simultaneously with DEAB at 4 hpf can rescue the
effects of DEAB (Figs. 4D, H), showing that DEAB is
acting specifically to block RA synthesis. By adding RA at
progressively later stages to DEAB-treated embryos, we
find that RA is not needed for normal hindbrain expression
of vhnf1 or hoxd4a until the time when expression of either
gene is normally initiated (Fig. 4I). Additionally, RA is not
required for specification of r7 until 9–10 hpf (Fig. 4J).
However, we also find that RA is not required for
specification of r5–r6 until about 10 hpf, slightly later than
r7 (Fig. 4J). This finding may appear to contradict the
conclusion that more anterior rhombomeres require RA
earlier than more posterior fates; however, this finding may
reveal that r5–r6 fates, and val and r5 krox-20 expression,
may have additional inputs that support their specification in
the absence of RA, whereas vhnf1, hoxd4a and r7 are more
directly or solely dependent on RA. Taken together, these
results contradict the hypothesis that increasingly more
posterior rhombomeres require increasingly longer dura-
tions of RA signaling. Instead, our experiments demonstrate
that a source of RA synthesis is required at distinct times for
the specification of each posterior rhombomere. Because
increasingly posterior rhombomeres require increasingly
higher levels of RA, our results suggest that the source of
RA increases during posterior hindbrain development.
An increased source of RA induces precocious expression of
posterior rhombomere markers
If the source of RA increases during posterior hindbrain
development and if this increasing source of RA promotes
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rhombomere markers, then generating a stronger endoge-
nous RA source earlier should turn on posterior markers
earlier. To locally increase the RA source, we placed RA
beads into the mesendodermal margin, the site of raldh2
expression (see Fig. 1), at 6 hpf, before vhnf1 and hoxd4a
normally initiate (see Fig. 1). The beads are placed
unilaterally, near the presumptive hindbrain (Woo and
Fraser, 1995). Control beads have no effect on the timing
or position of vhnf1 or hoxd4a expression (Figs. 5A, C, E,
G). However, RA beads cause precocious expression of
vhnf1 unilaterally, near the RA bead, at 7 hpf (Fig. 5B). If
these RA-bead-implanted embryos are allowed to develop
further, they show anterior expansion of vhnf1 on the RA-
bead side (Fig. 5D). By 10 hpf, RA beads also cause
precocious expression of hoxd4a unilaterally, near the RA
bead (Fig. 5F). At later stages, these embryos showanterior expansion of hoxd4a on the RA-bead side (Fig.
5H). The anterior ectopic expansion of vhnf1 and hoxd4a
at later stages reveals that the increased RA causes vhnf1
and hoxd4a to be induced and maintained in cells more
anterior than would normally express these genes. These
precocious inductions are concentration-dependent. vhnf1
is induced strongly and with high frequency by 1 mM
beads, as shown above, but 0.1 mM beads do not induce
precocious vhnf1 expression (n = 8). hoxd4a is induced
strongly and with high frequency by 10 mM RA beads, as
shown above, but, with 1 mM beads, hoxd4a is weakly
induced at 10 hpf in only 4/11 embryos. These results
reveal that vhnf1 and hoxd4a are competent to respond to
RA earlier than they normally initiate and that a stronger
source of RA is sufficient to promote their early induction
in more anterior cells. These results thus support our
hypothesis that the RA source becomes stronger over time,
providing a mechanism as to how RA progressively
induces increasingly more posterior rhombomere fates
during development (see Discussion).
RA acts through vHnf1 to regulate val expression
Our results above support a critical and likely direct role
for RA for the expression of vhnf1 and hoxd4a and for r7
specification. vhnf1 acts upstream of val in r5–r6 specifi-
cation (Sun and Hopkins, 2001). Because vhnf1 and val
expression are both dependent on RA (Fig. 2), we wanted to
address the relationships among RA, vhnf1 and val.
Previous work has shown that, upon loss of RA signaling,
vhnf1 overexpression can activate val (Hernandez et al.,Fig. 3. RA synthesis is required for initiation of posterior hindbrain
markers. (A–D) Control (A, C) and 5 AM DEAB-treated (B, D) embryos
are stained in blue for vhnf1 (A, B) and hoxd4a (C, D). Other markers in
red are pax2a (A–D) and krox-20 (C, D). Dorsal views show anterior to the
top. Treatments were initiated at 4 hpf (sphere stage), and embryos were
fixed at 9 hpf (90% epiboly) (A, B) or 10.6 hpf (2 s) (C, D). For vhnf1, 10
10 DEAB-treated embryos showed loss of expression. For hoxd4a, 10/10
DEAB-treated embryos showed loss of hindbrain expression as well as loss
of r5 krox-20 expression. r3, rhombomere 3 krox-20 expression. Scale bar
50 Am. (E) RA synthesis is required for initiation, but not maintenance, o
vhnf1 and hoxd4a. Embryos were treated with 5 AM DEAB beginning a
stages between 4 hpf and 11 hpf (3 s). Arrows point to normal initiation
times of vhnf1 and hoxd4a expression. For vhnf1 analysis, embryos were
treated until 10.3 hpf (1 s) then were fixed and stained for vhnf1 expression
For hoxd4a analysis, embryos were treated until 18 hpf (18 s) then were
fixed and stained for hoxd4a and krox-20 expression. Levels of hindbrain
expression were scored on a 0–4 scale, with 0 representing no expression
and 4 representing wild-type levels. n = 10 for each vhnf1 data point. n 
12 for each hoxd4a data point. (F) Specification of r5– r6 and r7 has distinc
temporal requirements for RA synthesis. The same series of treatments were
used as for panel (E). For r5 analysis, krox-20 expression was scored in 18
hpf embryos. For r6 analysis, val (non-overlapping r5 krox-20) expression
was scored in 18 hpf embryos. For r7 analysis, efnb2a expression was
scored in embryos fixed after treatment until 11.6 hpf (5 s). Rhombomere
length was scored on a 0–3 scale, with 0 representing no expression and 3
representing wild type or longer lengths of expression domains. n  20 fo
each r5 data point. n  10 for each r6 data point. n  14 for each r7 data
point. Error bars represent 95% confidence interval./
:
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Fig. 4. RA rescues DEAB treatment and is not required until posterior marker initiation. (A–H) Control (A, E), 1 nM RA-treated (B, F), 5 AM DEAB-treated
(C, G) and 5 AM DEAB + 1 nM RA-treated (D, H) embryos are stained in blue for vhnf1 (A–D) and hoxd4a (E–H). Other markers in red are pax2a and krox-
20. Dorsal views show anterior to the left. Treatments were initiated at 4 hpf (sphere stage), and embryos were fixed at 10.3 hpf (1 s) (A–D) or 18 hpf (18 s)
(E–H). r3, rhombomere 3 krox-20 expression. Scale bars: 50 Am. (I) RA can rescue DEAB treatment up to the time of either vhnf1 or hoxd4a initiation.
Embryos were treated with 5 AM DEAB beginning at 4 hpf then were additionally treated with 1 nM RA beginning at stages between 4 hpf and 11 hpf (3 s).
Arrows point to normal initiation times of vhnf1 and hoxd4a expression. For vhnf1 analysis, embryos were treated until 10.3 hpf then were fixed and stained for
vhnf1 expression. For hoxd4a analysis, embryos were treated until 18 hpf then were fixed and stained for hoxd4a and krox-20 expression. Levels of hindbrain
expression were scored on a 0–4 scale, with 0 representing no expression and 4 representing wild-type levels. n = 10 for each vhnf1 data point. n  18 for each
hoxd4a data point. 10/10 DEAB-treated/no RA controls showed little or no vhnf1 expression (see Fig. 3E). 12/12 DEAB-treated/no RA controls showed no
hoxd4a expression (see Fig. 3E). Other control embryos were treated with RA alone at each time point: vhnf1 (n = 10 each time point) and hoxd4a (n = 20 each
time point) expression appeared largely normal. (J) Rescue of r5– r6 and r7 has distinct temporal requirements for RA. The same series of treatments were used
as for panel (I). For r5 analysis, krox-20 expression was scored in 18 hpf embryos. For r6 analysis, val (non-overlapping r5 krox-20) expression was scored in
18 hpf (18 s) embryos. For r7 analysis, efnb2a expression was scored in embryos fixed after treatment until 11.6 hpf (5 s). Rhombomere length was scored on a
0–3 scale, with 0 representing no expression and 3 representing wild type or longer lengths of expression domains. n  20 for each r5 data point. n  13 for
each r6 data point. n  13 for each r7 data point. Error bars represent 95% confidence interval.
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activate val, we employed RA beads. In chick embryos, RA
beads placed by r4–r6 can induce expression of the val
ortholog Mafb anterior to r5–r6 in the hindbrain (Grapin-
Botton et al., 1998). We find that RA beads can induce
expression of both vhnf1 and val in the anterior hindbrain
(Figs. 6A–C). Compared to the vhnf1 induction, this val
induction appears more localized near its endogenous
domain (Fig. 6B). When analyzed at later stages, these
embryos continue to show ectopic val expression anterior to
r5–r6 (Fig. 6C). vhnf1 mutant embryos show essentially no
val expression (Fig. 6E; Sun and Hopkins, 2001), and RA
beads are not able to induce val expression in vhnf1 mutant
embryos (Fig. 6F). RA can still have effects in vhnf1 mutant
embryos as revealed by the altered r3 krox-20 pattern (Fig.
6F). These results show that RA acts through vHnf1 to
regulate val expression. Because val functions upstream of
Hox gene expression in r5–r6 (Prince et al., 1998a), this
pathway provides a mechanism for RA regulation of Hox
gene expression in r5–r6.Discussion
We have addressed the nature of RA activity during early
patterning of the zebrafish hindbrain. Here, we discuss the
roles of concentration-dependent RA signaling in activating
gene expression and rhombomere identity. We also discuss
how our results support a critical role for a temporally
increasing source of RA during hindbrain development.
Conserved concentration-dependent requirements for RA
signaling in posterior hindbrain patterning
We show that genes with important roles in early
posterior rhombomere specification, hoxb1b, vhnf1, hoxb1a
and hoxd4a, activate sequentially in the presumptive hind-
brain, each adjacent to raldh2-expressing paraxial meso-
derm, the source of RA synthesis (Fig. 1). We chose these
genes because of their early expression in, and requirements
for development of, r4 (hoxb1b, hoxb1a; McClintock et al.,
2002), r5–r6 (vhnf1; Sun and Hopkins, 2001) and r7
Fig. 5. RA beads can induce posterior hindbrain markers ectopically and prematurely. Embryos with control (A, C, E, G), 1 mM RA (B, D) or 10 mM RA (F, H)
beads placed in the margin at 6 hpf (shield stage) and stained in blue for vhnf1 at 7 hpf (65% epiboly) (A, B) or 10.3 hpf (1 s) (C, D) or for hoxd4a at 10 hpf (bud
stage) (E, F) or 11.3 hpf (4 s) (G, H). Markers in red are no tail (ntl, Schulte-Merker et al., 1992), which labels the margin and the shield/dorsal midline (A–B) and
the notochord (C–F) and also pax2a to label the MHB (C–H) and the early ear primordia (G–H). Dorsal views show anterior to the top. Arrows point to beads.
Arrowheads point to the shield/dorsal midline (A–B). (A–D) vhnf1 initiates prematurely on the RA-bead side (B) in 8/8 cases, compared with the control side (0/
8) and with control bead embryos (A, 0/8). If bead-implanted embryos are allowed to develop further, to 10.3 hpf, 10/10 control embryos show normal vhnf1
expression (C), and 9/9 embryos with 1mMRA beads show anterior expansion of vhnf1 on the RA-bead side (D). (E–H) hoxd4a initiates prematurely on the RA-
bead side (F) in 7/7 cases, compared with the control side (0/7) and with control bead embryos (E, 0/10). If these embryos are allowed to develop further, to 11.3
hpf, 10/10 control embryos show normal hoxd4a expression (G), and 9/9 embryos with 10 mMRA beads show anterior expansion of hoxd4a on the RA-bead side
(H). r3: rhombomere 3 krox-20 expression. Scale bar: 50 Am.
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zebrafish have not yet been determined. We addressed the
requirements for RA signaling in activating expression of
these genes. Previous studies have found that zebrafishFig. 6. RA induces val expression through vHnf1. (A–C) Embryos with 0.1
mM RA beads placed near the anterior presumptive hindbrain at 6 hpf
(shield stage) are stained in red for krox-20 and in blue for vhnf1 at 10.3 hpf
(1 s) (A), val at 10.3 hpf (B) or val at 15 hpf (12 s) (C). 13/13 0.1 mM RA
beads induced vhnf1 expression unilaterally in the anterior hindbrain,
generally surrounding the bead (A). 10/10 0.1 mM RA beads induced val
expression unilaterally in the anterior hindbrain (B). (D–F) Wild-type
sibling (D), vhnf1 mutant control (E) and vhnf1 mutant embryo with a 0.1
mM RA bead placed near the anterior presumptive hindbrain at 6 hpf (F).
Embryos are stained in blue for val and in red for krox-20 at about 11.3 hpf
(4 s). 3/8 control vhnf1 mutant embryos showed no val expression; 5/8
showed some weak bilateral val expression (E). RA beads are unable to
induce any val expression in vhnf1 mutants (F). 6/9 vhnf1 mutant embryos
with RA beads showed no val expression (F); 3/9 showed some very weak
bilateral val expression, similar to what is observed in control vhnf1 mutant
embryos. 14/14 wild-type sibling embryos with RA beads showed ectopic
unilateral val expression. Dorsal views show anterior to the left. Arrows
point to beads. r3: rhombomere 3 krox-20 expression. Scale bar: 50 Am.raldh2 mutants, or embryos exposed to moderate doses of
the RA-receptor inhibitor BMS493, have mild defects in
hindbrain patterning, including expansion of r3–r6 (Bege-
mann et al., 2001; Grandel et al., 2002). More recent studies
have shown that high doses of another RA-receptor
inhibitor, or the Raldh inhibitor DEAB, cause severe
posterior hindbrain defects in zebrafish, including loss of
val expression (Linville et al., 2004; Begemann et al.,
2004). We show that increasing doses of either BMS493 or
DEAB generate a series of phenotypes that resemble the
effects of increasing RA inhibition in other vertebrates,
where r7 is reduced or lost first, then r6, then r5 (Table 1;
Fig. 2). With the highest dose of either inhibitor that acts
specifically, we observe loss of r5–r7 accompanied by
posterior expansion of r3 and r4 (Table 1; Fig. 2),
mimicking the most severe phenotypes of RA inhibition
that have been reported in other vertebrates (reviewed by
Begemann and Meyer, 2001; Gavalas, 2002). Thus, we
demonstrate a series of RA concentration-dependent
requirements for zebrafish posterior hindbrain development.
The variety of approaches that have been used to inhibit RA
signaling in several vertebrates, yielding very similar
phenotypes, argues for the extremely conserved require-
ments for RA signaling in the vertebrate hindbrain, where
progressively more posterior rhombomeres require increas-
ingly higher levels of RA signaling for their development.
An increasing source of RA sequentially initiates the
expression of posterior rhombomere markers
In addition to concentration, timing of RA signaling has
been proposed to be an important component of RA action
Fig. 7. Hypothetical model of RA effects on rhombomere identity. (A) We
assume that the wild-type source of RA increases linearly over time (A,
pink line) and induces more and more posterior fates at regular defined
thresholds, noted on the y axis (A). We further assume that, as development
proceeds (time, x axis in A), RA signaling will continue to induce a specific
rhombomere fate until its concentration reaches the next higher threshold.
We also assume that there is a time at which RA can no longer continue to
induce hindbrain fates. This scenario leads to the production of r3– r7 with
equivalent lengths (B, wild type). With decreasing RA sources (green,
yellow, blue lines, A), the time it takes for the sources to achieve successive
thresholds increases (A). To calculate predicted rhombomere lengths for
each RA source in panel (A), we extrapolated the hypothetical RA-
inhibition lines shown in panel (A) and assumed that the length of time
between achieving each threshold would directly correspond to each
rhombomere’s length (B; data not shown).
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Meyer, 2001; Gavalas, 2002). Our finding that increasingly
more posterior hindbrain genes initiate expression sequen-
tially near the source of RA synthesis (Fig. 1) further
suggests an important role for the timing of RA signaling in
hindbrain patterning. We find that RA signaling is required
in a time- as well as concentration-dependent manner for
posterior rhombomere specification. We show that RA
inhibition just before the time of initiation of vhnf1 and
hoxd4a is sufficient to block their expression (Fig. 3). We
also show that the temporal requirements for RA signaling
proceed in an anterior–posterior direction, with r5–r6
requiring RA earlier than r7 (Fig. 3), consistent with
findings in other vertebrates (reviewed by Begemann and
Meyer, 2001; Gavalas, 2002).
The role of timing as well as concentration of RA
signaling has provided support against a static gradient of
RA acting across the hindbrain. The prevailing hypothesis
that integrates the time- and concentration-dependent
requirements for RA is that more posterior rhombomeres
need to be exposed to RA for longer time periods during
development (Gavalas, 2002; Maden, 2002). We directly
tested this hypothesis by rescuing DEAB treatments with
RA at later and later time points. We find that RA is not
needed for vhnf1 or hoxd4a expression until just at the time
when expression of either gene is normally initiated (Fig. 4).
These experiments strongly argue against the idea that more
posterior rhombomere markers require RA signaling for
longer time periods during development in order to be
activated. We then proposed an alternative hypothesis: that
an increasing source of RA during development could
account for both the time and concentration dependence of
RA. We directly tested and provided evidence for this
hypothesis by increasing the RA source with RA-labeled
beads and then examining early initiation of posterior
markers. Our RA bead experiments show that posterior
markers vhnf1 and hoxd4a not only respond to RA in a
concentration-dependent manner but also are competent to
respond to RA earlier than they normally initiate (Fig. 5).
These experiments strongly support our hypothesis that an
increasing source of RA sequentially initiates the expression
of posterior rhombomere markers during hindbrain develop-
ment. Despite the critical importance of understanding the
temporal role of RA in Hox gene regulation, to our
knowledge, only one other study has shown that RA can
initiate Hox gene expression precociously during develop-
ment (Roelen et al., 2002).
We propose that, as development proceeds, the source of
RA increases locally to sequentially induce increasingly
more posterior fates at higher and higher thresholds. Our
hypothesis thus provides an alternative view to either a
static gradient of RA acting across the hindbrain or more
posterior rhombomeres requiring longer exposure to RA.
The model in Fig. 7 illustrates our hypothesis. We assume
that the wild-type source of RA increases linearly over time
and induces increasingly more posterior fates at regulardefined thresholds (Fig. 7A). Genes and rhombomeres that
require only low levels of RA, such as hox1 genes and r4,
are thus initiated early, and those that require high levels of
RA, such as hoxd4a and r7, can only be initiated at later
stages when the source has grown. This scenario leads to the
production of r3–r7 with equivalent lengths (Fig. 7B, wild
type). Decreasing the RA source predicts rhombomere
defects that correspond to those observed experimentally
(Fig. 7). Interestingly, our assumption that the source of RA
normally increases linearly over time does a remarkably
good job of predicting the rhombomere phenotypes that are
observed experimentally upon inhibiting RA signaling (Fig.
7; see also Table 1). An RA level of 87.5% of wild type
would generate slightly expanded r3–r6 and reduced r7,
corresponding to the zebrafish raldh2 mutant phenotype.
An RA level of 62.5% of wild-type would generate
expanded r3–r5, reduced r6 and loss of r7, corresponding
to a 0.5 AM DEAB treatment. An RA level of 37.5% of
wild-type would lead to expanded r3 and r4 and loss of r5–
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predicts that, at an 87.5% RA level, r3 increases by about
13%, the same value directly measured by Grandel et al.
(2002) for the zebrafish raldh2 mutant r3. However, our
model also predicts that, at an 87.5% RA level, r5 and r6
each increase by about 13%, yet direct measurements of
zebrafish raldh2 mutants show that r5 increases only by
about 7% and r6 increases by about 17% (Grandel et al.,
2002).
Our model is supported by other experimental data.
Increasing the RA source too early, achieving increasingly
higher thresholds, would precociously induce increasingly
more posterior rhombomere fates, similar to what we
observe with increasing concentrations of RA beads (Fig.
5). Furthermore, our model predicts that decreasing the
wild-type source at a late stage would cause the production
of anterior rhombomere fates posterior to more posterior
rhombomere fates; for example, a drop in RA levels to the
r4 threshold at the time the r6 threshold has been reached
should produce r4 fates posterior to r5. Late RA inhibitor
treatments, which cause a patchy posterior spreading of r4–
r6 markers, may support this prediction (Dupe´ and Lum-
sden, 2001; L.M., unpublished observations).
While sequential signaling of the RA source has been
previously proposed (Maden, 2002), we suggest that a
critical addition to this model is the importance of the
temporally increasing RA source. A temporally increasing
source of RA could be generated by an increasing number of
cells expressing raldh2, as may occur during early zebrafish
hindbrain patterning (see Fig. 1), or by successively more
posterior mesoderm cells expressing increasing levels of
raldh2, as may occur during early chick hindbrain pattern-
ing (Swindell et al., 1999). In support of our increasing RA
source hypothesis, somite grafting experiments in chick
embryos have shown that the ability of somite tissue to
induce ectopic anterior Hoxb4 expression moves posteriorly
during development and seems to parallel changing levels of
raldh2 expression in the somites (Itasaki et al., 1996;
Swindell et al., 1999). One advantage of our model is that it
takes into account that morphogenetic movements during
gastrulation could affect the ability of mesodermal tissues to
signal to the hindbrain. As sequentially more posterior
hindbrain genes are activated during zebrafish gastrulation,
the mesodermal source of RA is shifting posteriorly relative
to the presumptive hindbrain (Fig. 1). Hindbrain cells
closest to the RA source at a given time will activate the
appropriate rhombomere identity based on the level of RA.
As these hindbrain neuroepithelial cells undergo cell
divisions and cell movements, they shift anteriorly relative
to the mesodermal source (Kimmel and Warga, 1987;
Kimmel et al., 1994; Concha and Adams, 1998).
Many other experiments have argued against a static
gradient of RA acting across the hindbrain (reviewed by
Maden, 2002). In particular, maternal RA administration or
RA bath treatments have been shown to at least partially
rescue hindbrain patterning in vitamin-A-deficient rat andquail embryos, in raldh2 mutant mice and in raldh2 mutant
fish (Gale et al., 1999; White et al., 2000; Niederreither et
al., 2000; Mic et al., 2002; Begemann et al., 2001; Grandel
et al., 2002). We show that even severe RA-synthesis
inhibition can be completely rescued with an RA bath (Fig.
4). Mic et al. (2002) show that RA rescue of Raldh2 mutant
mice appears to activate endogenous local sources of RA,
possibly helping to explain how a global RA treatment can
promote a normal rescued pattern. Other factors that
contribute to RA signaling or metabolism, such as the
Cyp26 RA-degradation enzymes, play important roles in
regulating RA activity in the hindbrain (reviewed by
Maden, 2002). In zebrafish, the expression pattern of
cyp26a1 in the anterior hindbrain is complementary to that
of early hox gene and raldh2 expression (Kudoh et al.,
2002; Dobbs-McAuliffe et al., 2004) and may support a
function for Cyp26 as a sink for an RA gradient. The
zebrafish cyp26a1 mutant shows a reduced hindbrain and
expanded anterior spinal cord phenotype that appears to be
opposite to that of the raldh2 mutant (Emoto et al., 2005).
However, additional studies of the zebrafish cyp26a1
mutant, as well as the examination of dynamic expression
and functions of Cyp26 enzymes in mouse embryos, have
suggested that these enzymes likely support dynamic
activity of RA in the hindbrain (Sirbu et al., 2005; Emoto
et al., 2005). In order to obtain further understanding of how
RA regulates gene expression and rhombomere identity in
the hindbrain, it will be necessary to identify the functions
of additional cyp26 genes. Furthermore, it is not yet known
which RA receptors are functioning in the zebrafish
hindbrain to mediate the signaling requirements that we
have described here. In the future, it will be critical to
determine which receptors are used in order to more
completely dissect the direct targets and actions of RA.Acknowledgments
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